News & Updates
Filter by Specialty:
Long-term relugolix combo helps with heavy periods, anaemia in women with uterine fibroids
Treatment with relugolix combination for up to 52 weeks yields sustained reductions in heavy menstrual bleeding as well as subsequent increases in iron stores in women with uterine leiomyomas, as shown in a study.
Long-term relugolix combo helps with heavy periods, anaemia in women with uterine fibroids
16 Nov 2022
PTSD may increase risk of cardiovascular diseases
Post-traumatic stress disorder (PTSD) appears to share a genetic risk with cardiovascular disease (CVD), indicating that PTSD is a factor that contributes to the development of coronary artery disease (CAD) and hypertension, reveals a study.
PTSD may increase risk of cardiovascular diseases
16 Nov 2022
Noninvasive scores use LSM to detect cirrhosis, advance fibrosis in NAFLD
Using liver stiffness measurements (LSM) combined with routine clinical parameters, Agile 3+, and Agile 4, both noninvasive scoring methods, can accurately identify advanced fibrosis (AF) and cirrhosis, respectively, in patients with nonalcoholic fatty liver disease (NAFLD), reports a new study.
Noninvasive scores use LSM to detect cirrhosis, advance fibrosis in NAFLD
16 Nov 2022
Adjunctive semaglutide yields additional weight loss in teens with obesity
Once-weekly treatment with semaglutide, when administered with lifestyle intervention, leads to greater reduction in body mass index among adolescents with obesity as compared with lifestyle intervention alone, as shown in the STEP TEENS study.
Adjunctive semaglutide yields additional weight loss in teens with obesity
16 Nov 2022
Depressive symptoms implicated in lung cancer via smoking habits
Individuals with greater depressive symptoms are at risk of developing lung cancer, with the association directly and indirectly attributed to smoking habits, as reported in a study.
